Associations Between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes
Mansour SG, Puthumana J, Reese PP, Hall IE, Doshi MD, Weng FL, Schröppel B, Thiessen-Philbrook H, Bimali M, Parikh CR. Associations Between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes. Kidney International Reports 2017, 2: 749-758. PMID: 28730184, PMCID: PMC5512592, DOI: 10.1016/j.ekir.2017.03.007.Peer-Reviewed Original ResearchDelayed graft functionAcute kidney injuryMonocyte chemoattractant protein-1MCP-1 concentrationsUMCP-1Graft failureDonor Acute Kidney InjuryRecipient delayed graft functionUrine MCP-1Deceased kidney donorsKidney transplant outcomesChemoattractant protein-1Organ procurement organizationsMinimal clinical utilityAllograft functionAllograft outcomesGraft functionKidney injuryTransplant outcomesKidney procurementStudy cohortKidney donorsIndependent associationMacrophage recruitmentClinical utilityBiomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review
Mansour SG, Puthumana J, Coca SG, Gentry M, Parikh CR. Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. BMC Nephrology 2017, 18: 72. PMID: 28219345, PMCID: PMC5319065, DOI: 10.1186/s12882-017-0490-0.Peer-Reviewed Original ResearchConceptsMatrix metalloproteinase-2Renal outcomesRenal functionRenal fibrosisStage ISystematic reviewWorse renal outcomeChronic kidney diseaseBiomarkers of fibrosisChemoattractant protein-1Diverse patient populationsGrowth factor βUrine biomarkersKidney diseaseMCP-1Patient populationDisease progressionMetalloproteinase-2FibrosisModerate positive correlationStage IIPatientsUnifying pathwayBiomarkersReliability of blood